Correction to: 3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: one disease - many faces
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Orphanet journal of rare diseases. - 17 (2022) , 16, ISSN: 1750-1172
- Ereignis
-
Veröffentlichung
- (wo)
-
Freiburg
- (wer)
-
Universität
- (wann)
-
2022
- Urheber
- DOI
-
10.1186/s13023-021-02154-z
- URN
-
urn:nbn:de:bsz:25-freidok-2240322
- Rechteinformation
-
Kein Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Grünert, Sarah
- Sass, Jörn Oliver
- Universität
Entstanden
- 2022
Ähnliche Objekte (12)
3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: one disease - many faces
3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: one disease - many faces
3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: one disease - many faces
Clinical and genetical heterogeneity of late-onset multiple acyl-coenzyme A dehydrogenase deficiency
Organoazidopathien im Blickpunkt des Neugeborenen-Screenings - Wandel des klinischen Phänotyps und kritische Aspekte des Screenings
Isovalerianazidämie : Klinik, Pathobiochemie und Therapie am Beispiel von 28 Patienten
2-methylacetoacetyl-coenzyme A thiolase (beta-ketothiolase) deficiency: one disease - two pathways
2-methylacetoacetyl-coenzyme A thiolase (beta-ketothiolase) deficiency: one disease - two pathways
Clinical and genetical heterogeneity of late-onset multiple acyl-coenzyme A dehydrogenase deficiency
Efficacy and safety of empagliflozin in glycogen storage disease type Ib: data from an international questionnaire
Neurological outcome in long‐chain hydroxy fatty acid oxidation disorders
3-hydroxy-3-methylglutaryl-coenzyme a lyase deficiency: a case report
3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: one disease - many faces
3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: one disease - many faces
3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: one disease - many faces
Clinical and genetical heterogeneity of late-onset multiple acyl-coenzyme A dehydrogenase deficiency
Organoazidopathien im Blickpunkt des Neugeborenen-Screenings - Wandel des klinischen Phänotyps und kritische Aspekte des Screenings
Isovalerianazidämie : Klinik, Pathobiochemie und Therapie am Beispiel von 28 Patienten
2-methylacetoacetyl-coenzyme A thiolase (beta-ketothiolase) deficiency: one disease - two pathways
2-methylacetoacetyl-coenzyme A thiolase (beta-ketothiolase) deficiency: one disease - two pathways
Clinical and genetical heterogeneity of late-onset multiple acyl-coenzyme A dehydrogenase deficiency
Efficacy and safety of empagliflozin in glycogen storage disease type Ib: data from an international questionnaire
Neurological outcome in long‐chain hydroxy fatty acid oxidation disorders
3-hydroxy-3-methylglutaryl-coenzyme a lyase deficiency: a case report
3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: one disease - many faces
3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: one disease - many faces
3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: one disease - many faces
Clinical and genetical heterogeneity of late-onset multiple acyl-coenzyme A dehydrogenase deficiency
Organoazidopathien im Blickpunkt des Neugeborenen-Screenings - Wandel des klinischen Phänotyps und kritische Aspekte des Screenings
Isovalerianazidämie : Klinik, Pathobiochemie und Therapie am Beispiel von 28 Patienten
2-methylacetoacetyl-coenzyme A thiolase (beta-ketothiolase) deficiency: one disease - two pathways
2-methylacetoacetyl-coenzyme A thiolase (beta-ketothiolase) deficiency: one disease - two pathways
Clinical and genetical heterogeneity of late-onset multiple acyl-coenzyme A dehydrogenase deficiency
Efficacy and safety of empagliflozin in glycogen storage disease type Ib: data from an international questionnaire
Neurological outcome in long‐chain hydroxy fatty acid oxidation disorders